Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2021
Pharma News, 2021
Lilly, Incyte report positive results for baricitinib in alopecia areata
Eli Lilly and Incyte have reported positive results from two Phase III trials evaluating their oral JAK inhibitor baricitinib in alopecia areata (AA).
Novo Nordisk plans study of oral semaglutide in obesity
Novo Nordisk is planning to initiate a Phase IIIa study of oral semaglutide in obesity, the Danish pharma company announced yesterday.
Bristol Myers, flush with pair of CAR-T approvals, blueprints first cell therapy factory in Europe
Bristol Myers Squibb's upcoming cell therapy plant in the Netherlands should help slash turnaround times for patients receiving its CAR-T therapies there.
Sleep duration associated with dementia risk
Research led by teams in Paris and London have found that UK civil servants who regularly slept for six hours or less in middle age have a higher risk of dementia.
Revolution Medicines Announces Dosing of First Patient in Phase 1/1b Clinical Study of RMC-5552 in Patients with Advanced Solid Tumors
REDWOOD CITY, CA, USA - April 21, 2021 - Revolution Medicines, Inc.
FDA report finds significant problems at Baltimore plant that contaminated Johnson & Johnson COVID vaccine
An inspection by the U.
KalVista Pharmaceuticals Provides Regulatory Update for Phase 2 Clinical Trial of KVD824
CAMBRIDGE, MA, USA & SALISBURY, UK I April 20, 2021 I KalVista Pharmaceuticals, Inc.
NYU Abu Dhabi researchers develop Micro-Fluidic Probe to isolate cancer spreading cells
Abu Dhabi, UAE, April 19.
CureVac Initiates Rolling Submission for COVID-19 Vaccine with Swissmedic
CureVac has filed for authorization of its two-dose messenger RNA-based COVID-19 vaccine, CVnCoV, by Switzerland’s pharmaceuticals regulator, Swissmedic.
Sanofi’s Sarclisa Earns Second EC Clearance for Multiple Myeloma
The European Commission (EC) has approved Sanofi’s Sarclisa (isatuximab) when combined with carfilzomib and dexamethasone for treating adults with relapsed multiple myeloma following...
China is starting clinical trials of a Covid vaccine that can be inhaled
China’s CanSino Biologics will be starting clinical trials for a Covid-19 vaccine that is administered through inhalation next week, the company’s co-founder and Chief Executive Xuefeng Yu told CN...
Indian pharma exports grow at 18% to $24.44 billion in FY 21 from $20.58 bn
Pharma exports from India witnessed over 18 per cent growth to USD 24.
50
51
52
53
54
55
56
57
58
